CNS 파마슈티컬스CNSP 주가

Which stocks are moving before the opening bell on Tuesday?

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

[EFFECT] EFFECT

[424B3] 424B3 — 424B3 PROSPECTUS

[4] 내부자 거래

[S-3] 증자 등록 — FORM S-3 REGISTRATION STATEMENT

[D] D

[SCHEDULE 13G/A] SCHEDULE 13G/A

CNS Pharmaceuticals Q1 EPS $(7.30) Misses $(5.37) Estimate

CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(7.30) per share which missed the analyst consensus estimate of $(5.37) by 35.94 percent. This is a 61.44 percent increase over losses of $(18.93) per share

CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress

Oversubscribed $22.5 million financing anticipated to enable CNS Pharmaceuticals to acquire differentiated, clinical-stage assets with identifiable near-term value-inflection catalysts, aligned with...